High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series

European Urology

Volumn 50, Issue 3, 2006, Pages 498-505

  Walz, Jochen ^a   Graefen, Markus ^b   Chun, Felix K H ^a   Erbersdobler, Andreas ^a   Haese, Alexander ^a   Steuber, Thomas ^a   Schlomm, Thorsten ^a   Huland, Hartwig ^a   Karakiewicz, Pierre I ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Prostate Cancer Center   (Germany)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Biopsy; Cancer; Diagnosis; Prostate; Saturation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROCESS DEVELOPMENT; PROSTATE CANCER; SATURATION BIOPSY; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

ADULT; AGED; BIOPSY; CARCINOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NOMOGRAMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 33746914793     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.03.026     Document Type: Article

References (20)

1. Keetch D.W., Catalona W.J., and Smith D.S. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151 (1994) 1571-1574
2. Djavan B., Ravery V., Zlotta A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol 166 (2001) 1679-1683
3. Borboroglu P.G., Comer S.W., Riffenburgh R.H., and Amling C.L. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 163 (2000) 158-162
4. Stewart C.S., Leibovich B.C., Weaver A.L., and Lieber M.M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166 (2001) 86-91 discussion 91-2
5. Chan T.Y., Chan D.Y., Stutzman K.L., and Epstein J.I. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?. J Urol 166 (2001) 2181-2184
6. Taylor J.A., Gancarczyk K.J., Fant G.V., and McLeod D.G. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer. Urology 60 (2002) 841-845
7. Rabets J.C., Jones J.S., Patel A., and Zippe C.D. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 172 (2004) 94-97
8. Patel A.R., Jones J.S., Rabets J., DeOreo G., and Zippe C.D. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 63 (2004) 87-89
9. Fleshner N., and Klotz L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology 60 (2002) 93-97
10. McNeal J.E., Villers A.A., Redwine E.A., Freiha F.S., and Stamey T.A. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66 (1990) 1225-1233
11. Gleason D.F. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M. (Ed). Urologic pathology: the prostate (1977), Lea & Ferbiger, Philadelphia 171-197 chp 9
12. Dugan J.A., Bostwick D.G., Myers R.P., et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 275 (1996) 288
13. Van Houwelingen J.C., and Le Cessie S. Predictive value of statistical models. Stat Med 9 (1990) 1303
14. Atkinson A.C. A note on the generalized information criterion for choice of a model. Biometrika 67 (1980) 413
15. Lopez-Corona E., Ohori M., Scardino P.T., Reuter V.E., Gonen M., and Kattan M.W. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 170 (2003) 1184-1188
16. Yanke B.V., Gonen M., Scardino P.T., and Kattan M.W. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173 (2005) 421-424
17. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
18. Specht M.C., Kattan M.W., Gonen M., Fey J., and Van Zee K.J. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12 (2005) 654-659
19. Henke R.P., Kruger E., Ayhan N., Hubner D., Hammerer P., and Huland H. Immunohistochemical detection of p53 protein in human prostatic cancer. J Urol 152 (1994) 1297-1301
20. Singh H., Canto E.I., Shariat S.F., et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 171 (2004) 1089-1092